CN105327104A - 一种雾霾清肺饮品 - Google Patents
一种雾霾清肺饮品 Download PDFInfo
- Publication number
- CN105327104A CN105327104A CN201510898643.7A CN201510898643A CN105327104A CN 105327104 A CN105327104 A CN 105327104A CN 201510898643 A CN201510898643 A CN 201510898643A CN 105327104 A CN105327104 A CN 105327104A
- Authority
- CN
- China
- Prior art keywords
- parts
- herba
- fructus
- under
- temperature
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 210000004072 lung Anatomy 0.000 title claims abstract description 24
- 239000000463 material Substances 0.000 claims abstract description 7
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract description 4
- 239000003814 drug Substances 0.000 claims description 24
- 239000002671 adjuvant Substances 0.000 claims description 14
- 238000012545 processing Methods 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 229940079593 drug Drugs 0.000 claims description 10
- 210000000582 semen Anatomy 0.000 claims description 10
- 235000013361 beverage Nutrition 0.000 claims description 9
- 239000009609 fructus phyllanthi Substances 0.000 claims description 9
- 239000000047 product Substances 0.000 claims description 9
- 241000628997 Flos Species 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 7
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims description 6
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 6
- 230000015572 biosynthetic process Effects 0.000 claims description 6
- 150000001875 compounds Chemical class 0.000 claims description 6
- 239000003651 drinking water Substances 0.000 claims description 6
- 235000020188 drinking water Nutrition 0.000 claims description 6
- 238000005755 formation reaction Methods 0.000 claims description 6
- 239000001630 malic acid Substances 0.000 claims description 6
- 235000011090 malic acid Nutrition 0.000 claims description 6
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 claims description 5
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 5
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 5
- 229960004998 acesulfame potassium Drugs 0.000 claims description 5
- 235000010358 acesulfame potassium Nutrition 0.000 claims description 5
- 239000000619 acesulfame-K Substances 0.000 claims description 5
- 235000004279 alanine Nutrition 0.000 claims description 5
- 238000004140 cleaning Methods 0.000 claims description 5
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 5
- 239000000811 xylitol Substances 0.000 claims description 5
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 5
- 235000010447 xylitol Nutrition 0.000 claims description 5
- 229960002675 xylitol Drugs 0.000 claims description 5
- 239000000284 extract Substances 0.000 claims description 4
- 239000008187 granular material Substances 0.000 claims description 4
- 230000008569 process Effects 0.000 claims description 4
- 239000002994 raw material Substances 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 3
- 238000013467 fragmentation Methods 0.000 claims description 3
- 238000006062 fragmentation reaction Methods 0.000 claims description 3
- 239000003205 fragrance Substances 0.000 claims description 3
- 238000004108 freeze drying Methods 0.000 claims description 3
- 239000012535 impurity Substances 0.000 claims description 3
- 244000005700 microbiome Species 0.000 claims description 3
- 238000000874 microwave-assisted extraction Methods 0.000 claims description 3
- 230000010355 oscillation Effects 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- 238000010298 pulverizing process Methods 0.000 claims description 3
- 230000000630 rising effect Effects 0.000 claims description 3
- 238000005070 sampling Methods 0.000 claims description 3
- 239000007921 spray Substances 0.000 claims description 3
- 238000012859 sterile filling Methods 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 238000003860 storage Methods 0.000 claims description 3
- 238000009210 therapy by ultrasound Methods 0.000 claims description 3
- 235000013399 edible fruits Nutrition 0.000 abstract description 2
- 241000185686 Apocynum venetum Species 0.000 abstract 1
- 244000227573 Desmodium styracifolium Species 0.000 abstract 1
- 244000119298 Emblica officinalis Species 0.000 abstract 1
- 235000015489 Emblica officinalis Nutrition 0.000 abstract 1
- 241000935235 Fritillaria meleagris Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 241000234435 Lilium Species 0.000 abstract 1
- 244000274050 Platycodon grandiflorum Species 0.000 abstract 1
- 235000006753 Platycodon grandiflorum Nutrition 0.000 abstract 1
- 240000004274 Sarcandra glabra Species 0.000 abstract 1
- 235000010842 Sarcandra glabra Nutrition 0.000 abstract 1
- 241001412228 Scaphium lychnophorum Species 0.000 abstract 1
- 244000185386 Thladiantha grosvenorii Species 0.000 abstract 1
- 235000011171 Thladiantha grosvenorii Nutrition 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 235000021018 plums Nutrition 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 20
- 210000002345 respiratory system Anatomy 0.000 description 13
- 206010011224 Cough Diseases 0.000 description 10
- 239000000203 mixture Substances 0.000 description 10
- 208000024891 symptom Diseases 0.000 description 10
- 206010062717 Increased upper airway secretion Diseases 0.000 description 9
- 239000000428 dust Substances 0.000 description 9
- 210000003800 pharynx Anatomy 0.000 description 9
- 208000026435 phlegm Diseases 0.000 description 9
- 230000036541 health Effects 0.000 description 8
- 206010036790 Productive cough Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 206010028748 Nasal obstruction Diseases 0.000 description 6
- 206010039101 Rhinorrhoea Diseases 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000010753 nasal discharge Diseases 0.000 description 6
- 230000017531 blood circulation Effects 0.000 description 5
- 239000013618 particulate matter Substances 0.000 description 5
- 206010035653 pneumoconiosis Diseases 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 239000003440 toxic substance Substances 0.000 description 5
- 201000007100 Pharyngitis Diseases 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 239000003390 Chinese drug Substances 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 208000018569 Respiratory Tract disease Diseases 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 206010006451 bronchitis Diseases 0.000 description 2
- 239000004568 cement Substances 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 239000010419 fine particle Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000002427 irreversible effect Effects 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000002685 pulmonary effect Effects 0.000 description 2
- 208000005069 pulmonary fibrosis Diseases 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000000779 smoke Substances 0.000 description 2
- 230000000391 smoking effect Effects 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- -1 vehicle exhaust Substances 0.000 description 2
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 1
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 1
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 244000132059 Carica parviflora Species 0.000 description 1
- 235000014653 Carica parviflora Nutrition 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 206010009152 Chronic tonsillitis Diseases 0.000 description 1
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- 201000006306 Cor pulmonale Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 241000202807 Glycyrrhiza Species 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000019025 Hypokalemia Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 241000219071 Malvaceae Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000028571 Occupational disease Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 235000011158 Prunus mume Nutrition 0.000 description 1
- 244000018795 Prunus mume Species 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 208000004186 Pulmonary Heart Disease Diseases 0.000 description 1
- 208000037656 Respiratory Sounds Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 241000220222 Rosaceae Species 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 206010001093 acute tonsillitis Diseases 0.000 description 1
- IAJILQKETJEXLJ-RSJOWCBRSA-N aldehydo-D-galacturonic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-RSJOWCBRSA-N 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003005 anti-senility effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 239000010692 aromatic oil Substances 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 239000003245 coal Substances 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 239000003897 fog Substances 0.000 description 1
- 239000003665 fog water Substances 0.000 description 1
- 239000000295 fuel oil Substances 0.000 description 1
- 239000003517 fume Substances 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000002955 immunomodulating agent Substances 0.000 description 1
- 230000002584 immunomodulator Effects 0.000 description 1
- 229940121354 immunomodulator Drugs 0.000 description 1
- 239000002440 industrial waste Substances 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 239000002799 interferon inducing agent Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 239000009438 liyan Substances 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 210000003928 nasal cavity Anatomy 0.000 description 1
- 210000001331 nose Anatomy 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 201000001245 periodontitis Diseases 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 208000024896 potassium deficiency disease Diseases 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000002633 protecting effect Effects 0.000 description 1
- 206010037833 rales Diseases 0.000 description 1
- 230000004202 respiratory function Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000000405 serological effect Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 1
- 235000015500 sitosterol Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 210000005090 tracheal smooth muscle Anatomy 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000001755 vocal effect Effects 0.000 description 1
- 238000009941 weaving Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/24—Apocynaceae (Dogbane family), e.g. plumeria or periwinkle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8966—Fritillaria, e.g. checker lily or mission bells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8967—Lilium, e.g. tiger lily or Easter lily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
一种雾霾清肺饮品,其特征在于:包括下列重量份数的原料药:罗汉果10~30,草珊瑚15~20,浙贝母1~15、金银花1~15,甘草1~15,百合1~15,桔梗5~10,胖大海5~10、乌梅1~5,余甘子1~5,广金钱草1~2份,罗布麻1~2份,辅料1~3。
Description
技术领域
本发明属于中药技术领域,特别是关于治疗呼吸道雾霾侵害的一种雾霾清肺饮品及其制备方法。
背景技术
粉尘就是特指在生产过程中形成的,并能长时间漂浮在空气中的固体颗粒。随着工业生产规模的不断扩大,生产性粉尘的种类和数量也不断增多,同时,许多生产性粉尘在形成之后,表面往往还能吸附其他的气态或液态有害物质,成为其他有害物质的载体。可吸入粉尘、呼吸性粉尘等生产性粉尘是污染作业环境的主要职业病危害因素,尘肺病是指劳动者在职业活动中,因吸入粉尘而发生的肺组织纤维化为主的疾病。肺组织纤维化形成的矽结节是不可逆转的。得上尘肺病,特别是矽肺,会逐渐发展,最后因肺脏失去呼吸功能,导致死亡。
我国接触职业危害人数、职业病患者累计数量、死亡数量及新发病人数量,均居世界首位。据有关部门统计,我国的职业病人以尘肺病为主,占全部职业病的70%以上,尘肺病以煤工尘肺、矽肺最为严重,尘肺病患者中有半数以上为煤工尘肺,更由于受工作、就业、生活环境硬件不可逆因素影响,水泥、纺织、矿山及其所属居民生活区均有此病发生,为一个地方区域、社会性通病、顽症,严重危害人体健康。
专家分析,PM2.5(是指空气中直径小于或等于2.5微米的颗粒物,也称为可入肺颗粒物)吸附的大气里面的毒性物质,进入到呼吸道以后,被身体吸收,对体内的影响是全方位的。近30年来,我国公众吸烟率不断下降,但肺癌患病率却上升了4倍多。目前普遍认为这可能与雾霾天增加有一定的关系。很多人已经把雾霾天气比喻成为大自然的“吸烟室”。不但浓雾缠绕、能见度非常低的天气会对人体健康产生影响,时而有雾时而多云的天气也会有同样的问题。雾霾天对人体心脑血管疾病的影响也很严重,会阻碍正常的血液循环,导致心血管病、高血压、冠心病、脑溢血,可能诱发心绞痛、心肌梗塞、心力衰竭等,使慢性支气管炎出现肺源性心脏病等。气象专家和医学专家认为,由细颗粒物造成的灰霾天气对人体健康的危害甚至要比沙尘暴更大。粒径10微米以上的颗粒物,会被挡在人的鼻子外面;粒径在2.5微米至10微米之间的颗粒物,能够进入上呼吸道,但部分可通过痰液等排出体外,也会被鼻腔内部的绒毛阻挡,对人体健康危害相对较小;而粒径在2.5微米以下的细颗粒物不易被阻挡,被吸入人体后会直接进入支气管,干扰肺部的气体交换,引发包括哮喘,支气管炎和心血管等方面的疾病。进入肺泡的微尘可迅速被吸收、不经过肝脏解毒直接进入血液循环,分布到全身,损害血红蛋白输送氧的能力,对贫血和血液循环障碍的病人来说,可能产生严重后果。人体的生理机构决定了对PM2.5没有任何过滤、阻拦能力,而PM2.5对人类健康的危害却随着医学技术的进步,逐步暴露出其恐怖的一面。雾霾当前,当借助药力,开提肺气,润肺化痰以助肺的自洁能力,使有害颗粒物质随痰排出。
中药不仅具有耐药性低、副作用和不良反应少等优点,而且还有调节免疫功能、改善血液循环、解热镇痛及抗菌消炎等综合功效,其在防治雾霾吸入侵害方面具有独特的优势和广阔的发展前景。
发明内容
本发明人经过反复研究,并通过体外和临床试验的反复验证,终于找到了有更好疗效的治疗呼吸道雾霾侵害的中药组合物,从而完成了本发明。本研究针对上述病因病机,采用有针对性而且具有独特治疗呼吸道雾霾侵害作用的中草药配制而成。该组合物主要由桔梗、浙贝母、罗汉果、甘草等组成,具有开提肺气,润肺祛痰,提升气道自洁能力,排除雾霾等颗粒有害物质之功效,临床上可用于治疗或预防由工业废气、汽车尾气、燃油尘、硫酸盐、餐饮油烟尘、建筑水泥尘、煤烟尘、空气中的灰尘、空气的细菌和病毒等污染物附着于大雾水滴上被吸入后对人体呼吸道产生影响所导致的呼吸道疾病。
本发明的目的是:克服现有技术的不足,提供一种能够有效治疗或预防由雾霾侵害所导致的呼吸道疾病且无毒副作用的饮品。
本发明的另一目的是:提供了该饮品的制备方法,满足市场的需求。
本发明解决其技术问题所采用的技术方案是:一种雾霾清肺饮品,包括下列重量份数的原料药:罗汉果10~30,草珊瑚15~20,浙贝母1~15、金银花1~15,甘草1~15,百合1~15,桔梗5~10,胖大海5~10、乌梅1~5,余甘子1~5,广金钱草1~2份,罗布麻1~2份,辅料1~3,按照以下方法制作而成:
(1)取金银花、甘草、百合、桔梗、余甘子、广金钱草、罗汉果、胖大海、罗布麻、草珊瑚、浙贝母、乌梅,除不可食用杂质及霉变部分,置于开放的、上下振幅振动6~8mm的水平运动振动筛面上,进行动态喷淋清洗,振动筛水平运行速率1~3m/min,喷淋水流速6~10m/s,将水沥干,用日光晒干或于35~50℃温度条件下干燥,烘干至干燥度≥85%,,对原料进行初粉碎或切细粒度为0.5~2mm的颗粒,喷洒饮用水或纯净水,使粗粉在浸润的状态下放置0.5~1小时之后,在60~80℃温度条件下干燥恒压保持20h,进行真空冷冻干燥后粉碎,备用;
(2)将步骤(1)所得物按比例混合均匀后加水煎煮三次,合并三次过滤液,减压浓缩即得浸膏;
(3)将步骤(2)获得浸膏按质量份数比1︰(25~30)加入饮用水,搅拌均匀在温度25~30℃条件下超声波处理10~20min,促进物料中功效成分的溶出,同时对物料进行破碎和微粒化,然后立即进入微波振荡提取和杀菌一体化处理阶段,微波提取条件为真空度0.09MPa、温度65~80℃、处理时间10~15min,同时使物料温度升高、质地软化、杀灭有害微生物,得到混合料备用;
(4)无菌条件下将经步骤(3)处理得到的混合料冷却至45~55℃,加入辅料,搅拌混合均匀,在压力30~50MPa、温度45~55℃条件下进行均质匀化处理,使产物组织均匀、口感柔滑细腻,具有特殊的芳香;
(5)无菌灌装:将步骤(4)得到产物无菌条件下灌入经过杀菌处理的容器中、封口,贮存,
(6)产品抽检、印码、装箱入库。
所述辅料为木糖醇、L~丙氨酸、安赛蜜、苹果酸中的一种或几种构成。
从中医学来看,甘草可治五脏六腑寒热邪气、脾胃虚弱、倦怠乏力、心悸气短,可补脾益气,清热解毒,祛痰止咳,缓急止痛,调和诸药,久服可轻身延年。西医研究表明,甘草不仅具有抗炎、抗过敏、抗病毒和保肝解毒及增强免疫功能等作用,还具有抗癌防癌、干扰素诱生剂及细胞免疫调节剂等功能。甘草的这些有益作用使得甘草适用于四季养生茶饮。加上甘草的甜度很高,可调和异味,保证了养生茶的口感。然而,甘草的用量是需要好好把握的,否则容易升高血压,导致水肿、低血钾等副作用。本发明中的原料配比合理,可充分发挥甘草的有益保健作用,而避免甘草过量带来的副作用。
其中桔梗味苦、辛、性平,开提肺气,润肺利咽祛痰,为君药;浙贝母苦、寒,清肺散结,化痰润燥,助桔梗开泄祛痰除霾,为臣药;罗汉果甘凉,润肺利咽止咳,即助桔梗、浙贝母润肺,又借其甘甜以矫味,为佐使药;甘草甘平,益气补中,解毒祛痰,调和诸药,为使药。全方辛开与苦降并举,苦中回甘,药性平和,共奏开提肺气,润肺祛痰之功,顾护肺脏抵御尘霾侵害。
胖大海:为梧桐科植物胖大海的干燥成熟种子,含半乳糖醛酸、阿拉伯糖、半乳糖、胖大海素、西黄耆胶粘素等,本发明选择其具有的清热润肺、利咽解毒、化痰清音的功效。广金钱草具有消炎作用;罗布麻对气管平滑肌有松弛作用;能有效缓解咳嗽造成的咽部肿胀。
乌梅:为蔷薇科落叶乔木植物梅的近成熟果实,经烟火熏制而成,温度保持在40℃左右,焙2-3昼夜,然后闷2-3天,使其变成黑色。含柠檬酸、苹果酸、琥珀酸、糖类、谷甾醇、维生素c等成分,可生津止咳、改善肝脏机能,软化血管,防老抗衰,并具有理想的抗菌作用,在本发明中还有个很重要的作用是提供酸酸的口感。
余甘子能显著抑制急性炎症的发展,改善和缓解炎性症状,草珊瑚叶可提取芳香油,全草可入药,味苦,辛,性平;具有抗菌消炎、祛风除湿、活血止痛等疗效,金银花茶味甘,性寒,具有清热解毒、疏散风热的作用。金银花有清热解毒、疏利咽喉、消暑除烦的作用。可治疗暑热症、泻痢、流感、疮疖肿毒、急慢性扁桃体炎、牙周炎等病。
该饮品于治疗或预防呼吸道雾霾侵害,疗效确切,且无毒副作用,在大范围发病的地区和时间,作为通用方用于治疗与预防皆有效,剂型和制备工艺适合工业化大批量生产。
具体实施方式
实施例1
一种雾霾清肺饮品,包括下列重量份数的原料药:罗汉果10,草珊,浙贝母1、金银花1,甘草1,百合1,桔梗5,胖大海5、乌梅1,余甘子1,广金钱草1,罗布麻1,辅料1,辅料为木糖醇、L~丙氨酸、安赛蜜、苹果酸中的一种或几种构成。
按照以下方法制作而成:
(1)取金银花、甘草、百合、桔梗、余甘子、广金钱草、罗汉果、胖大海、罗布麻、草珊瑚、浙贝母、乌梅,除不可食用杂质及霉变部分,置于开放的、上下振幅振动6~8mm的水平运动振动筛面上,进行动态喷淋清洗,振动筛水平运行速率1~3m/min,喷淋水流速6~10m/s,将水沥干,用日光晒干或于35~50℃温度条件下干燥,烘干至干燥度≥85%,,对原料进行初粉碎或切细粒度为0.5~2mm的颗粒,喷洒饮用水或纯净水,使粗粉在浸润的状态下放置0.5~1小时之后,在60~80℃温度条件下干燥恒压保持20h,进行真空冷冻干燥后粉碎,备用;
(2)将步骤(1)所得物按比例混合均匀后加水煎煮三次,合并三次过滤液,减压浓缩即得浸膏;
(3)将步骤(2)获得浸膏按质量份数比1︰(25~30)加入饮用水,搅拌均匀在温度25~30℃条件下超声波处理10~20min,促进物料中功效成分的溶出,同时对物料进行破碎和微粒化,然后立即进入微波振荡提取和杀菌一体化处理阶段,微波提取条件为真空度0.09MPa、温度65~80℃、处理时间10~15min,同时使物料温度升高、质地软化、杀灭有害微生物,得到混合料备用;
(4)无菌条件下将经步骤(3)处理得到的混合料冷却至45~55℃,加入辅料,搅拌混合均匀,在压力30~50MPa、温度45~55℃条件下进行均质匀化处理,使产物组织均匀、口感柔滑细腻,具有特殊的芳香;
(5)无菌灌装:将步骤(4)得到产物无菌条件下灌入经过杀菌处理的容器中、封口,贮存,
(6)产品抽检、印码、装箱入库。
实施例2
制备方法同实施例1,其与实施例1的区别在于组分的比例不同,该实施例的各组分为:罗汉果30,草珊瑚20,浙贝母15、金银花15,甘草15,百合15,桔梗10,胖大海10、乌梅5,余甘子5,广金钱草2份,罗布麻2份,辅料3,辅料为木糖醇、L~丙氨酸、安赛蜜、苹果酸中的一种或几种构成。
实施例3
制备方法同实施例1,其与实施例1的区别在于组分的比例不同,该实施例的各组分为:罗汉果20,草珊瑚20,浙贝母10、金银花10,甘草10,百合10,桔梗10,胖大海8、乌梅85,余甘子5,广金钱草2份,罗布麻2份,辅料3,辅料为木糖醇、L~丙氨酸、安赛蜜、苹果酸中的一种或几种构成。
保健效果试验
一呼吸道雾霾侵害实验
1.临床资料
本组病例均为2015年8月至2015年12月确诊的呼吸道雾霾侵害的患者急性起病;伴有咳嗽、咳痰、流涕、鼻塞、喷嚏、咽干等症状;年龄35~69岁,符合下列中西医诊断标准的患者,90例患者随机分为治疗组(中药组合物)45例,对照组(咽炎片组)45例。治疗组45例随机分配到实施方式例1、2、3组(简称治疗组A、B、C)各15例,对照组45例随机分为三组(简称对照组A、B、C)各15例,两组在性别、年龄、病程和病情分布上无统计学意义(P〉0.05)。
2诊断标准
体检:咽部充血,扁桃体肿大,两肺呼吸音稍粗糙或不粗糙,伴或不伴有干湿罗音;血清学检查:外周血常规白细胞计算及分类在正常范围之间或白细胞计数偏高;X线胸片检查基本正常。
3.治疗方法
治疗组给予中药组合物,口服,每日两次,每次用量100ml;对照组用咽炎片片0.25克/次,每日1次,口服。儿童酌减。疗程为5天。
4.疗效标准
治疗五天内咳嗽、咳痰、流涕、鼻塞、喷嚏、咽干等临床症状体征消失;
显效:治疗五天内咳嗽、咳痰、流涕、鼻塞、喷嚏、咽干等临床症状体征减轻2/3以上;
有效:治疗五天内咳嗽、咳痰、流涕、鼻塞、喷嚏、咽干等临床症状体征减轻2/3~1/3;
无效:治疗五天内自觉或其他症状均无明显改善或加重。
5.结果
运用本发明实施方式例1的中药组合物(治疗组A)治疗呼吸道雾霾侵害,结果表明:比较两组患者总有效率及用药前后咳嗽、咳痰、流涕、鼻塞、喷嚏、咽干等临床症状改善情况,治疗组A临床改善总有效率83.11%;对照组A临床改善总有效率30.66%,治疗组A与对照组A比较差异有统计学意义(P<0.05)。在临床治疗观察中未发现毒副作用。临床结果提示:本发明实施方式例2中药组合物治疗呼吸道雾霾侵害疗效满意,在缓解临床症状时间及总有效率及治愈率方面中药组均优于咽炎片片组。
运用本发明实施方式例2的中药组合物(治疗组B)治疗呼吸道雾霾侵害,结果表明:比较两组患者总有效率及用药前后咳嗽、咳痰、流涕、鼻塞、喷嚏、咽干等临床症状改善情况,治疗组B临床改善总有效率88.34%;对照组B临床改善总有效率32.95%;治疗组B与对照组B比较差异有统计学意义(P<0.05)。在临床治疗观察中未发现毒副作用。临床结果提示:本发明实施方式例3中药组合物治疗呼吸道雾霾侵害疗效满意,在缓解临床症状时间及总有效率及治愈率方面中药组均优于咽炎片片组。
以上内容是结合具体的优选实施方式对本发明所作的进一步详细说明,不能认定本发明的具体实施只局限于这些说明。对于本发明所属技术领域的普通技术人员来说,在不脱离本发明构思的前提下,还可以做出若干简单推演或替换,都应当视为属于本发明的保护范围。
下边结合试验例来进一步说明本发明的效果。
Claims (2)
1.一种雾霾清肺饮品,其特征在于:包括下列重量份数的原料药:罗汉果10~30,草珊瑚15~20,浙贝母1~15、金银花1~15,甘草1~15,百合1~15,桔梗5~10,胖大海5~10、乌梅1~5,余甘子1~5,广金钱草1~2份,罗布麻1~2份,辅料1~3,按照以下方法制作而成:
(1)取金银花、甘草、百合、桔梗、余甘子、广金钱草、罗汉果、胖大海、罗布麻、草珊瑚、浙贝母、乌梅,除不可食用杂质及霉变部分,置于开放的、上下振幅振动6~8mm的水平运动振动筛面上,进行动态喷淋清洗,振动筛水平运行速率1~3m/min,喷淋水流速6~10m/s,将水沥干,用日光晒干或于35~50℃温度条件下干燥,烘干至干燥度≥85%,,对原料进行初粉碎或切细粒度为0.5~2mm的颗粒,喷洒饮用水或纯净水,使粗粉在浸润的状态下放置0.5~1小时之后,在60~80℃温度条件下干燥恒压保持20h,进行真空冷冻干燥后粉碎,备用;
(2)将步骤(1)所得物按比例混合均匀后加水煎煮三次,合并三次过滤液,减压浓缩即得浸膏;
(3)将步骤(2)获得浸膏按质量份数比1:(25~30)加入饮用水,搅拌均匀在温度25~30℃条件下超声波处理10~20min,促进物料中功效成分的溶出,同时对物料进行破碎和微粒化,然后立即进入微波振荡提取和杀菌一体化处理阶段,微波提取条件为真空度0.09MPa、温度65~80℃、处理时间10~15min,同时使物料温度升高、质地软化、杀灭有害微生物,得到混合料备用;
(4)无菌条件下将经步骤(3)处理得到的混合料冷却至45~55℃,加入辅料,搅拌混合均匀,在压力30~50MPa、温度45~55℃条件下进行均质匀化处理,使产物组织均匀、口感柔滑细腻,具有特殊的芳香;
(5)无菌灌装:将步骤(4)得到产物无菌条件下灌入经过杀菌处理的容器中、封口,贮存;
(6)产品抽检、印码、装箱入库。
2.根据权利要求1所述的雾霾清肺饮品,其特征在于,所述辅料为木糖醇、L~丙氨酸、安赛蜜、苹果酸中的一种或几种构成。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510898643.7A CN105327104A (zh) | 2015-12-08 | 2015-12-08 | 一种雾霾清肺饮品 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510898643.7A CN105327104A (zh) | 2015-12-08 | 2015-12-08 | 一种雾霾清肺饮品 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105327104A true CN105327104A (zh) | 2016-02-17 |
Family
ID=55278010
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510898643.7A Withdrawn CN105327104A (zh) | 2015-12-08 | 2015-12-08 | 一种雾霾清肺饮品 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105327104A (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105795269A (zh) * | 2016-03-23 | 2016-07-27 | 东莞市东卓中天生物科技有限公司 | 清咽净肺的饮料制备方法 |
CN107279391A (zh) * | 2017-07-18 | 2017-10-24 | 佛山瑞匀医疗器械有限公司 | 润喉清肺茶及其制造方法 |
CN107510778A (zh) * | 2017-09-01 | 2017-12-26 | 河南科技大学 | 一种清肺防霾饮及其制备方法 |
CN108477457A (zh) * | 2018-04-06 | 2018-09-04 | 张奉明 | 一种清霾益肺的铁皮石斛组合物及其制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103127369A (zh) * | 2013-03-04 | 2013-06-05 | 高雪 | 一种治疗呼吸道雾霾侵害的中药组合物及其制备方法 |
CN104000195A (zh) * | 2014-06-06 | 2014-08-27 | 吉林省维伊康生物科技有限公司 | 清肺排毒口服液及其生产方法 |
-
2015
- 2015-12-08 CN CN201510898643.7A patent/CN105327104A/zh not_active Withdrawn
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103127369A (zh) * | 2013-03-04 | 2013-06-05 | 高雪 | 一种治疗呼吸道雾霾侵害的中药组合物及其制备方法 |
CN104000195A (zh) * | 2014-06-06 | 2014-08-27 | 吉林省维伊康生物科技有限公司 | 清肺排毒口服液及其生产方法 |
Non-Patent Citations (3)
Title |
---|
江苏新医学院: "《中药大辞典(上册)》", 31 May 1986, 上海科学技术出版社 * |
陈蔚文: "《岭南道地药材研究》", 31 October 2007, 广东科技出版社 * |
高渌汶: "《菜篮子与健康•益肺套餐》", 30 November 2005, 上海中医药大学出版社 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105795269A (zh) * | 2016-03-23 | 2016-07-27 | 东莞市东卓中天生物科技有限公司 | 清咽净肺的饮料制备方法 |
CN107279391A (zh) * | 2017-07-18 | 2017-10-24 | 佛山瑞匀医疗器械有限公司 | 润喉清肺茶及其制造方法 |
CN107510778A (zh) * | 2017-09-01 | 2017-12-26 | 河南科技大学 | 一种清肺防霾饮及其制备方法 |
CN107510778B (zh) * | 2017-09-01 | 2020-10-09 | 河南科技大学 | 一种清肺防霾饮及其制备方法 |
CN108477457A (zh) * | 2018-04-06 | 2018-09-04 | 张奉明 | 一种清霾益肺的铁皮石斛组合物及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103127369A (zh) | 一种治疗呼吸道雾霾侵害的中药组合物及其制备方法 | |
CN105360524A (zh) | 一种雾霾清肺茶 | |
CN106138360A (zh) | 一种中药组合物及其制备方法、应用 | |
CN105327104A (zh) | 一种雾霾清肺饮品 | |
CN104042947A (zh) | 一种清咽利喉制剂及其制备方法 | |
CN106421039A (zh) | 一种防治雾霾引起的病症的中药组合物、其制备方法和含其的口罩 | |
CN107174638A (zh) | 一种止咳浸膏及其制备方法 | |
CN105148017A (zh) | 一种具有润肺止咳功能的饮料 | |
CN102641356B (zh) | 一种治疗呼吸道病毒感染性疾病的中药组合物及其制备方法 | |
CN101524497A (zh) | 一种治疗咽炎的中药制剂 | |
CN105998599A (zh) | 一种治疗病毒性呼吸道感染的中药组合物及其制备方法 | |
CN105381193A (zh) | 一种雾霾清肺含片 | |
CN105326888A (zh) | 治疗小儿痰热壅肺型哮喘的药物组合物 | |
CN102657804B (zh) | 一种治疗病毒性感冒的中药组合物及其制备方法 | |
CN106511740B (zh) | 一种包含人参的产品及其制备方法 | |
CN104840734B (zh) | 清咽保健中药组合物及其制备方法和应用 | |
CN103211984A (zh) | 一种治疗慢性鼻炎的药物组合物及其制备方法 | |
CN102949526A (zh) | 治疗慢性咽炎保健品颗粒及其制备方法 | |
CN102641335A (zh) | 一种治疗上呼吸道病毒感染的中药组合物及其制备方法 | |
CN106692504B (zh) | 一种清咽止咳润肺防雾霾保健食品及其制备方法 | |
CN105250843A (zh) | 一种治疗风热咳嗽的药物 | |
CN106266535A (zh) | 一种用于痰湿体质和润肺清咽的配方及其制备方法 | |
CN101700375B (zh) | 小儿外感咳嗽的中药制剂 | |
CN105106601A (zh) | 一种用于治疗急性鼻咽炎的药物制剂 | |
CN111281921A (zh) | 一种治疗感冒、肺炎、肠炎、肾炎的肺形草银翘解毒消炎组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20160217 |
|
WW01 | Invention patent application withdrawn after publication |